Spokane Valley-based Incyte Diagnostics has agreed to acquire Pendleton, Ore.-based Blue Mountain Pathology, says Incyte CEO Tom Rehwald.
The two pathology practices signed a letter of intent to combine in early August, and Incyte is aiming for a Jan. 1